➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

FERRLECIT Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Ferrlecit patents expire, and when can generic versions of Ferrlecit launch?

Ferrlecit is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in FERRLECIT is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.

Summary for FERRLECIT
US Patents:0
Finished Product Suppliers / Packagers: 1
Clinical Trials: 12
Drug Prices: Drug price information for FERRLECIT
What excipients (inactive ingredients) are in FERRLECIT?FERRLECIT excipients list
DailyMed Link:FERRLECIT at DailyMed
Drug patent expirations by year for FERRLECIT
Drug Prices for FERRLECIT

See drug prices for FERRLECIT

Recent Clinical Trials for FERRLECIT

Identify potential brand extensions & 505(b)(2) entrants

Rambam Health Care CampusPhase 4
University of MarylandPhase 4
University of North Carolina, Chapel HillPhase 4

See all FERRLECIT clinical trials

Pharmacology for FERRLECIT

US Patents and Regulatory Information for FERRLECIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us FERRLECIT ferric oxyhydroxide INJECTABLE;INJECTION 020955-001 Feb 18, 1999 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.